ATE154937T1 - Steroide zur behandlung von prostatisch- hypertrophe, ihre herstellung und verwendung - Google Patents
Steroide zur behandlung von prostatisch- hypertrophe, ihre herstellung und verwendungInfo
- Publication number
- ATE154937T1 ATE154937T1 AT93302937T AT93302937T ATE154937T1 AT E154937 T1 ATE154937 T1 AT E154937T1 AT 93302937 T AT93302937 T AT 93302937T AT 93302937 T AT93302937 T AT 93302937T AT E154937 T1 ATE154937 T1 AT E154937T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted alkyl
- treatment
- alkyl
- prostatic
- hypertrophics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9981692 | 1992-04-20 | ||
JP32804392 | 1992-12-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE154937T1 true ATE154937T1 (de) | 1997-07-15 |
Family
ID=26440917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93302937T ATE154937T1 (de) | 1992-04-20 | 1993-04-15 | Steroide zur behandlung von prostatisch- hypertrophe, ihre herstellung und verwendung |
Country Status (25)
Country | Link |
---|---|
US (3) | US5536714A (de) |
EP (2) | EP0567271B1 (de) |
JP (1) | JP2514778B2 (de) |
KR (1) | KR0146680B1 (de) |
CN (2) | CN1041095C (de) |
AT (1) | ATE154937T1 (de) |
AU (1) | AU656852B2 (de) |
CA (1) | CA2094300C (de) |
CZ (2) | CZ283791B6 (de) |
DE (1) | DE69311837T2 (de) |
DK (1) | DK0567271T3 (de) |
ES (1) | ES2105108T3 (de) |
FI (1) | FI931765A (de) |
GR (1) | GR3024896T3 (de) |
HK (1) | HK1000303A1 (de) |
HU (1) | HU219579B (de) |
ID (1) | ID18576A (de) |
IL (1) | IL105478A (de) |
MX (1) | MX9302300A (de) |
NO (1) | NO304891B1 (de) |
NZ (1) | NZ247449A (de) |
PH (1) | PH31052A (de) |
RU (2) | RU2097387C1 (de) |
TW (2) | TW401420B (de) |
ZA (1) | ZA932732B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1259419B (it) * | 1991-05-24 | 1996-03-18 | Erba Carlo Spa | Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi |
HUT72467A (en) * | 1992-04-30 | 1996-04-29 | Smithkline Beecham Corp | 17alpha and 17beta-substituted estra-1,3,5(10)-triene-3-carboxylic acids, pharmaceutical compositions containing them, intermediates and process for their production |
US5683995A (en) * | 1992-11-18 | 1997-11-04 | Smithkline Beecham Corporation | 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors |
GB9224148D0 (en) * | 1992-11-18 | 1993-01-06 | Smithkline Beecham Corp | Compounds |
US5641765A (en) * | 1992-11-18 | 1997-06-24 | Smithkline Beecham Corporation | 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase |
WO1995006461A1 (en) * | 1993-09-03 | 1995-03-09 | Smithkline Beecham Corporation | Stabilized tablet formulation |
GB9324371D0 (en) * | 1993-11-26 | 1994-01-12 | Erba Carlo Spa | Side chain fluoro substituted 3-carboxysteroids |
GB9411103D0 (en) * | 1994-06-03 | 1994-07-27 | Smithkline Beecham Corp | Compounds |
GB9415183D0 (en) * | 1994-07-28 | 1994-09-21 | Erba Carlo Spa | 3-carboxysteroids with a fluorinated side-chain |
AU8779898A (en) * | 1997-08-11 | 1999-03-01 | Weider Nutrition International, Inc. | Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors |
US5879711A (en) * | 1997-11-07 | 1999-03-09 | Sequeira; Joel A. | Stable antiandrogenic gel composition |
CA2330611A1 (en) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
US6428769B1 (en) * | 1999-05-04 | 2002-08-06 | Aradigm Corporation | Acute testosterone administration |
US7258850B2 (en) * | 1999-05-04 | 2007-08-21 | Aradigm Corporation | Methods and compositions for treating erectile dysfunction |
EP1434786A4 (de) * | 2001-10-03 | 2009-03-25 | Merck & Co Inc | Androstan-17-beta-carboxamide als modulatoren des androgenrezeptors |
US20060148725A1 (en) * | 2001-12-21 | 2006-07-06 | The Miriam Hospital | Selective 11beta HSD inhibitors and methods of use thereof |
AU2002361861A1 (en) * | 2001-12-21 | 2003-07-30 | Rhode Island Hospital | SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF |
WO2004097002A2 (en) * | 2003-04-29 | 2004-11-11 | The Miriam Hospital | SELECTIVE TESTICULAR 11β-HSD INHIBITORS AND METHODS OF USE THEREOF |
CA2608144C (en) | 2005-04-28 | 2012-11-13 | Proteus Biomedical, Inc. | Pharma-informatics system |
US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
US7604386B2 (en) * | 2005-11-18 | 2009-10-20 | Federal-Mogul World Wide, Inc | Lamp assembly having a socket made from high temperature plastic |
EP2398500B1 (de) | 2009-02-20 | 2019-03-13 | 2-BBB Medicines B.V. | Arzneiabgabesystem auf glutathion-basis |
SG175896A1 (en) | 2009-05-06 | 2011-12-29 | Lab Skin Care Inc | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
WO2011004242A2 (en) * | 2009-07-09 | 2011-01-13 | Aurobindo Pharma Limited | An improved process for the preparation of dutasteride |
CN111362999B (zh) * | 2020-03-16 | 2022-03-29 | 江苏联环药业股份有限公司 | 一种爱普列特杂质及其制备方法和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU527030B2 (en) * | 1978-04-13 | 1983-02-10 | Merck & Co., Inc. | 4-aza-17-substituted-5a-androstan-3-ones |
IL74365A (en) * | 1984-02-27 | 1990-07-26 | Merck & Co Inc | 17beta-(n-t.-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one and pharmaceutical compositions containing it |
US4910226A (en) * | 1987-04-29 | 1990-03-20 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
US4946834A (en) * | 1988-12-23 | 1990-08-07 | Smithkline Beecham Corporation | Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors |
US5032586A (en) * | 1989-08-24 | 1991-07-16 | Smithkline Beecham Corporation | 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase |
US5137882A (en) * | 1990-06-11 | 1992-08-11 | Holt Dennis A | Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors |
US5091380A (en) * | 1990-06-28 | 1992-02-25 | Merck & Co., Inc. | N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors |
IE76452B1 (en) * | 1990-10-29 | 1997-10-22 | Sankyo Co | Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use |
AU1893492A (en) * | 1991-04-17 | 1992-11-17 | Merck & Co., Inc. | Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor |
US5196411A (en) * | 1991-08-16 | 1993-03-23 | Merck & Co., Inc. | 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors |
-
1993
- 1993-04-15 DE DE69311837T patent/DE69311837T2/de not_active Expired - Fee Related
- 1993-04-15 DK DK93302937.3T patent/DK0567271T3/da active
- 1993-04-15 EP EP93302937A patent/EP0567271B1/de not_active Expired - Lifetime
- 1993-04-15 AT AT93302937T patent/ATE154937T1/de not_active IP Right Cessation
- 1993-04-15 EP EP96104843A patent/EP0725074A3/de not_active Withdrawn
- 1993-04-15 ES ES93302937T patent/ES2105108T3/es not_active Expired - Lifetime
- 1993-04-16 NO NO931401A patent/NO304891B1/no not_active IP Right Cessation
- 1993-04-19 AU AU36984/93A patent/AU656852B2/en not_active Ceased
- 1993-04-19 HU HU9301155A patent/HU219579B/hu not_active IP Right Cessation
- 1993-04-19 ZA ZA932732A patent/ZA932732B/xx unknown
- 1993-04-19 RU RU93005334/04A patent/RU2097387C1/ru not_active IP Right Cessation
- 1993-04-19 PH PH46066A patent/PH31052A/en unknown
- 1993-04-19 FI FI931765A patent/FI931765A/fi unknown
- 1993-04-19 CA CA002094300A patent/CA2094300C/en not_active Expired - Fee Related
- 1993-04-19 RU RU95101838/04A patent/RU2114861C1/ru not_active IP Right Cessation
- 1993-04-20 JP JP5092840A patent/JP2514778B2/ja not_active Expired - Fee Related
- 1993-04-20 MX MX9302300A patent/MX9302300A/es unknown
- 1993-04-20 CZ CZ93678A patent/CZ283791B6/cs not_active IP Right Cessation
- 1993-04-20 CZ CZ97900A patent/CZ284206B6/cs not_active IP Right Cessation
- 1993-04-20 KR KR1019930006652A patent/KR0146680B1/ko not_active IP Right Cessation
- 1993-04-20 CN CN93105911A patent/CN1041095C/zh not_active Expired - Fee Related
- 1993-04-20 NZ NZ247449A patent/NZ247449A/en unknown
- 1993-04-20 TW TW083108455A patent/TW401420B/zh not_active IP Right Cessation
- 1993-04-20 TW TW082103024A patent/TW238312B/zh active
- 1993-04-21 IL IL105478A patent/IL105478A/en not_active IP Right Cessation
- 1993-04-27 ID IDP980293A patent/ID18576A/id unknown
-
1995
- 1995-01-19 US US08/375,264 patent/US5536714A/en not_active Expired - Fee Related
- 1995-03-31 US US08/414,909 patent/US5760025A/en not_active Expired - Fee Related
-
1996
- 1996-03-20 US US08/618,850 patent/US5717088A/en not_active Expired - Fee Related
-
1997
- 1997-08-26 CN CN97117777A patent/CN1195666A/zh active Pending
- 1997-09-25 HK HK97101841A patent/HK1000303A1/xx not_active IP Right Cessation
- 1997-10-01 GR GR970402543T patent/GR3024896T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE154937T1 (de) | Steroide zur behandlung von prostatisch- hypertrophe, ihre herstellung und verwendung | |
DE69120500D1 (de) | Azasteroide zur Behandlung prostatischer Hypertrophie, ihre Herstellung und Verwendung | |
EP1114823A3 (de) | Substituierte Benzylamin-Stickstoff enthaltende nichtaromatische Heterocyclen | |
ATE121385T1 (de) | Harnstoffderivate, ihre herstellung und ihre verwendung bei der therapie. | |
DE69200284D1 (de) | Verwendung von 4-(3-trifluormethylphenyl)-1,2,3,6-Tetrahydropyridinderivaten als freie Radikalfänger. | |
ES2016017A6 (es) | Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico. | |
UA66888C2 (uk) | 3-тетрагідропіридин-4-іл індоли, спосіб їх отримання та спосіб лікування психічних розладів | |
DE69911373D1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
DE69533214D1 (de) | 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme | |
MX9800705A (es) | Compuestos heterociclicos, composiciones para tratar isquemia de miocardio que los contiene, y procedimiento para su preparacion. | |
DE69916577D1 (de) | Azetidincarboxamid-derivate zur behandlung von zns störungen | |
ATE220665T1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
CA2171972A1 (en) | Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |